SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 920.93 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 267.76 |
| Book Value / Share | 4.91 |
| Price / Book | n/a |
| NCAV ($M) | 265.81 |
| NCAV / Share | 4.88 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.50 |
| Return on Assets (ROA) | -0.36 |
| Return on Equity (ROE) | -0.37 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 12.60 |
| Current Ratio | 12.60 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 289.42 |
| Assets | 291.37 |
| Liabilities | 23.61 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -145.69 |
| Net Income | -134.22 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -120.13 |
| Cash from Investing | -0.54 |
| Cash from Financing | 2.68 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,734 | 14,924 | 31.72 | |
| 5,357 | 38,585 | 13.88 | |
| 24,668 | 58,720 | 42.01 | |
| 15,390 | 166,165 | 9.26 | |
| 8,376 | 31,333 | 26.73 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PEPG – PepGen Inc. | PGEN – Precigen, Inc. |
| PHAT – Phathom Pharmaceuticals, Inc. | PLRX – Pliant Therapeutics, Inc. |
| PMVP – PMV Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io